No black box warning on record for Ziextenzo

As of the latest FDA labeling reviewed, Ziextenzo (PEGFILGRASTIM-BMEZ) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ziextenzo medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Fatal splenic rupture: Evaluate patients who report left upper abdominal or shoulder pain for an enlarged spleen or splenic rupture. ( 5.1 ) • Acute respiratory distress syndrome (ARDS): Evaluate patients who develop fever, lung infiltrates, or respiratory distress. Discontinue ZIEXTENZO in patients with ARDS. ( 5.2 ) • Serious hypersensitivity reactions, including ana

No black box warning on record for Ziextenzo

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Fatal splenic rupture: Evaluate patients who report left upper abdominal or shoulder pain for an enlarged spleen or splenic rupture. ( 5.1 ) • Acute respiratory distress syndrome (ARDS): Evaluate patients who develop fever, lung infiltrates, or respiratory distress. Discontinue ZIEXTENZO in patients with ARDS. ( 5.2 ) • Serious hypersensitivity reactions, including ana

Ziextenzo Black Box Warning

No black box warning on record for Ziextenzo

Other warnings & precautions

Ziextenzo Black Box Warning

No black box warning on record for Ziextenzo

Other warnings & precautions